- MetLife recently held its annual outlook meeting and, in my opinion, the main takeaway from the presentation was that the bull case for this insurer remains intact.
- Specifically, MetLife appears to be properly positioned for 2019 and beyond.
- I am long MetLife, and I plan to stay long the stock.
MetLife's ($MET) stock has fallen out of favor over the last few quarters, which is shown by the fact that its shares are underperforming the broader market by approximately 24 percentage points on a YTD basis.
However, the important thing to remember is that the stock has performed pretty much in line with the other insurers (and in a broader context, the financials in general), as this sector has faced significant downward pressure due to industry concerns.
However, as I recently described here, I believe that MetLife's stock is trading at attractive levels and is worthy of investment dollars, of course, if you are willing (and able) to hold onto shares for the next two to three years.
Read more here.